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ABSTRACT 
EFFECTS OF MALFORMED OR ABSENT VALVES TO LYMPHATIC FLUID 
TRANSPORT AND LYMPHEDEMA IN VIVO IN MICE 
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BACHELOR OF ENGINEERING, SHIVAJI UNIVERSITY, INDIA 
 
MASTER OF SCIENCE, UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Juan M. Jiménez 
 
 
Lymph is primarily composed of fluid and proteins from the blood circulatory 
system that drain into the space surrounding cells, interstitial space. From the interstitial 
space, the fluid enters and circulates in the lymphatic system until it is delivered into the 
venous system.  In contrast to the blood circulatory system, the lymphatic system lacks a 
central pumping organ dictating the predominant driving pressure and velocity of lymph.  
Transport of lymph via capillaries, pre-collecting and collecting lymphatic vessels relies 
on the synergy between pressure gradients, local tissue motion, valves and lymphatic 
vessel contractility. The direction of lymph transport is regulated by bicuspid valves 
distributed throughout pre-collecting and collecting lymphatic vessels.  
Effective transport of lymph into the venous system is of prime importance. 
Disruption of lymph transport, because of impaired lymphatic function, reduced numbers 
of vessels or valvular insufficiencies can have severe health consequences, including 
lymphedema for which current clinical therapies are not curative.  The lymphatic valves 
are usually bicuspid, however, congenital malformations in the valve such as single 
vii 
leaflet valve formation and arrested lymphatic valve development are observed and can 
cause lymphedema. 
Here we employ 4-week-old mice to study the effects of valves and malformed 
valves on lymph transport shedding light into some of the potentially underlying 
consequences of lymphedema.  Polyethylene glycol (PEG) coated latex particles were 
injected into the inguinal lymph node of anesthetized mice.  Particle displacement 
measurements through efferent lymphatic vessels yielded velocity, wall shear stress, 
vorticity and strain of the efferent lymph flow field carrying lymph from subdermal 
inguinal lymph nodes. Lymphatic vessel endothelial Prox1 green fluorescent protein 
(GFP) marker enabled the detection of lymphatic vessel walls and valves. Flow field, 
flow velocity, flow rate, velocity profiles, wall shear stress, vorticity and strain values 
were compared in regions downstream of normal and malformed valves in two wild type 
mice. A Clec2-deficient mouse, which experiences lymphatic development defects and is 
used as a lymphedema model, was employed to further elucidate the lymphatic valves on 
transport.   
The absence of centralized pumping yields highly variable lymphatic flow cycles 
varying from one to fifteen seconds. The presence of lymphatic valves introduces 
boundary conditions that yield spatial and temporal flow gradients increasing the degree 
of complexity of lymph transport.  The valves dictate the trajectory of the particles and 
promote the formation of recirculation zones. Even in the presence of valves, lymph flow 
commonly reverses. Congenital defects like a single leaflet valve lowers the lymph flow 
efficiency and promotes higher wall shear stress regions.  Furthermore, the absence of 
viii 
functional valves in the Clec2-deficient mouse not displaying lymphedema yielded lymph 
flow lacking the pulsatility that characterizes normal lymphatic flow. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
1.1 The Lymphatic System 
The circulatory system is comprised of two separate systems: the cardiovascular 
system, which distributes blood, and the lymphatic system, which circulates lymph. The 
blood circulatory system is a closed system, whereas the lymphatic system is one-way 
open system. 
Arterial blood carries oxygen, nutrients, and hormones for the cells. Oxygenated 
blood travels arteries, arterioles and capillaries to perfuse tissues throughout the body. 
During this process fluid, primarily plasma, travels between cells as interstitial fluid and 
it delivers its nourishing products to the cells. This fluid along with cellular waste is 
transported via the lymphatic system into the venous system. 
One of the primary roles of the lymphatic system is to transport this excess 
interstitial fluid back to the blood circulation via the thoracic duct into the venous system 
[1], [2]. Along with the excess interstitial fluid, excessive proteins and waste are 
transported back to the circulation. The lymphatic system also acts as a conduit for 
immune cells and facilitates the immune response. Lymph nodes across the network filter 
the interstitial flow and provide immunity against bacteria, viruses and waste. Thus, 
along with being an integral part of the circulatory system, the lymphatic system is also 
an integral part of the immune system. 
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1.1.1 Anatomy and Physiology 
Unlike the cardiovascular system, the lymphatics do not have a centralized 
pumping organ. The lymphatic system is composed of a network of vessels, termed as 
lymphatics, lymph nodes and lymphoid organs. Anatomically, the vessels of the lymphatic 
system are sub-divided into the initial lymphatics, pre-collecting lymphatics, collecting 
lymphatics and organs such as nodes. The origins of the lymphatic system, known as the 
initial lymphatics, are dispersed throughout the capillary network of the mesentery. The walls 
of the initial lymphatics are usually not contractile and only lined with endothelial cells.  
All tissues connected perfused by the cardiovascular system have supporting 
lymphatics to serve as its drainage system, with the notable exception of bone marrow 
and the central nervous system [3]. Lymphatic capillaries are tiny, thin-walled blind-
ended vessels composed of a single monolayer of non-fenestrated lymphatic endothelial 
cells (LEC) and are present in all tissues in the interstitial spaces [4]. The lymphatic 
capillaries are strategically placed and anatomically constructed to permit a continuous 
and rapid removal of transient interstitial fluids and plasma proteins from the interstitium. 
The endothelial cells are arranged in an overlapping pattern and each cell is attached to 
nearby tissue by anchoring filaments to keep them from collapsing under higher fluid 
pressures [5]. The anchoring filaments are mainly composed of the emilin-1 and fibrillin 
proteins, which may attach to the LECs via molecules such as αvβ3 integrin [6], [7]. 
When pressure in the interstitium is greater than in the capillaries, the flap-like 
endothelial cells separate slightly and interstitial fluid enters the lymphatic capillary. In 
contrast, if pressure is greater inside the lymphatic capillary, the LECs adhere closely, to 
prevent retrograde flow. The fluid entered in the capillaries is now termed as lymph 
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which is a clear fluid with an approximate density of 1000 kgm-3 [8] and the dynamic 
viscosity ranging between 1.5 × 10-3 and 2.2 × 10-3 cP [9]. 
The lymph travels from the capillaries into the pre-collecting lymphatics. The pre-
collecting lymphatics connect the lymphatic capillaries to the collecting vessels. They 
contain bicuspid one-way valves; however, the distribution of valves is irregular and even 
comprise occasional single leaflet valves [10]. Smooth muscle cells are observed in the 
pre-collecting and larger lymphatic vessels. The presence of smooth muscle cells 
decreases vessel permeability in these vessels, while its absence enables fluid adsorption 
in the initial lymphatics. 
 
 
Figure 1: Organization of lymphatic vascular system [7]    
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The collecting lymphatics deliver lymphatic fluid to the lymph nodes through 
afferent vessels and drain the lymph away from the node through efferent lymph vessels. 
The collecting lymphatic vessels connect with chains of lymph nodes that sieve and 
monitor lymph to mount an immune response when necessary. The collecting lymphatics 
differ from the capillaries and pre-collector vessels, especially in lumen diameter. 
Intraluminal lymphatic valves are present primarily to ensure net antegrade flow. The 
part of the vessel between two valves is known as a lymphangion. The lymphatics is 
composed of a series of connected lymphangions.  
Lymph propulsion is the outcome of contractions of the lymphangions and by 
external motion of skeletal muscle, arteries and veins. In this manner, the lymph is 
transported by pumping towards the venous system in the neck region [2]. Lymph from 
the left side of the body, abdomen, and both lower limbs ends up in the thoracic duct, the 
largest lymphatic vessel that runs alongside the aorta, and finally connects with the left 
subclavian vein. Lymph from the right upper arm, thorax, and head is returned to the 
right subclavian vein via the right lymphatic trunk [11]. In healthy adult individuals, the 
lymphatic system returns as much as eight liters of interstitial fluid with 20–30 g of 
protein per liter to the venous circulation every day [3]. The wall structure of these 
vessels are similar to that of blood vessels and consists of three layers: the intima, media 
and adventitia [12].  
1. Intima: The inner layer of lymphatic vessels is composed of a single monolayer 
of lymphatic endothelial cells (LEC), also known as the lymphatic endothelium. 
The lymph is in direct contact with the endothelial cells. Lymphatic endothelium 
is further discussed in detail in next sub-section. 
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2. Media: Smooth muscle cells are arranged in a circular fashion around the 
endothelium that help alter the lumen pressure by contracting and relaxing. The 
activity of smooth muscles allows lymph vessels to slowly pump lymph fluid 
through the body. Smooth muscle cells are absent in initial lymphatics. An 
extensible protein called elastin enables reshaping of the vessel after contraction. 
3. Adventitia: The outermost layer of the vessel is the adventitia, consisting of 
fibrous tissue. It is primarily composed of collagen and serves to anchor the 
lymph vessels to structures within the body for stability. Larger lymph vessels 
have many more layers of adventitia than the smaller lymphatic vessels. 
Adventitia is absent in initial and pre-collecting lymphatics. 
 
The lymphatic vessels are comparable to blood vessels, however, structure of 
smooth muscle, elastin and collagen networks in the lymphatic walls are not present in 
blood vessels [13]. Blood vessel walls are not designed to contract spontaneously, since 
the heart pumps the blood around the body. Blood vessels experience mainly radial 
stresses [13]. The lymphatic walls actively pump the lymph which creates longitudinal as 
well as radial stresses. The forces present in the cardiovascular system are much higher 
than in the lymphatic system. Additionally, as the velocities in the lymphatic system are 
much slower, the Reynolds numbers are significantly lower than in the cardiovascular 
system. 
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1.1.2 Lymphatic Endothelium 
Lymphatic endothelial cells (LECs) originate from embryonic blood endothelial 
cells (BECs) during embryogenesis. The hematopoietic signalling proteins SLP76 and 
SYK are known to regulate blood and lymphatic vascular differentiation during 
development [14]. The two endothelial cell types, therefore, share features such as flat 
morphology, apico-basal polarity and certain common endothelial-specific proteins. 
However, many phenotypic and genetic characteristics are unique for one or the other 
vessel type and are routinely used to differentiate between blood and lymph vessels in 
histological specimens and vascular biology. Recent studies have demonstrated that the 
BECs and LECs represent differentiated cell lineages without evidence of any 
interconversion between the distinguishing phenotypic properties [15]. 
The LECs are terminally differentiated cells distinct from blood vascular 
endothelial cells [16]. This has enabled the discovery of lymphatic vascular-specific 
molecules that are used for identification of lymphatic vessels in tissues, as well as for 
finding targets for the specific induction or inhibition of lymphatic vessel growth in 
pathological conditions [16], [17]. Blood vessels express plasmalemma vesicle associated 
protein 1 (PV-1), endoglin, neuropilin-1 (NRP-1) and collagen IV [18]. Lymph vessels 
on the other hand express markers such as podoplanin (PDPN), lymphatic endothelial 
hyaluronan receptor-1 (LYVE-1) [19], vascular endothelial growth factor receptor-3 
(VEGFR-3) and prospero related homeobox 1 (PROX-1) [18]. Among these, the 
transcription factor PROX-1 is known to be the most specific lineage marker for LECs 
[20] and for the downregulation of numerous BEC-specific genes [21]. LYVE-1 
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expression remains high in lymphatic capillaries and decreases in collecting lymphatic 
vessels [22]. 
ECs that line the lumen of blood and lymphatic vessels are exposed to mechanical 
forces generated by fluid flow. The endothelium responds to shear stress through various 
mechanosensitive pathways depending on the kind and the magnitude of shear stresses 
(9). LECs exposed to shear stresses due to flow have shown upregulation in genes such as 
FOXC2, GATA2, ITGA9 and CX37 during development and promote valve formation 
[23]. PROX-1expression is not altered by lymphatic fluid shear forces. LYVE-1 
expression is significantly downregulated. 
Modulating shear stress through flow rate has been found to induce release of the 
vasodilator nitric oxide (NO) in lymphatic vessels. As in blood vessels, the SMCs lining 
the lymphatic vessels respond to changes in Ca2+ concentration, which generally alter 
vessel contraction [24], [25]. NO acts at multiple points in the Ca2+ contraction pathway 
to modulate Ca2+ release and uptake, as well as the enzymes responsible for force 
production [26], [27]. Blocking or enhancing NO activity can dramatically affect 
pumping behavior.  Studies have investigated and revealed that NO release is driven by 
upregulation of enzyme endothelial nitric oxide synthase (eNOS) in LECs.  NO 
produced by eNOS in the vascular endothelium plays crucial roles in regulating 
vascular tone and cellular proliferation. Another study has revealed the role of shear 
stress in phosphorylation of eNOS, thus upregulating NO [28] . 
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1.1.3 Lymphatic Valves 
One of the main structural features of lymphatic vessels are their valves, which 
are normally semilunar structures attached to opposite sides of the lymphatic 
endothelium. Valves are present even in the blood circulatory system, but only in low 
pressure venous circulation. They function similarly to lymphatic valves, however are 
more dependent on skeletal muscle contractions. Lymphatic valves are found in larger 
lymph vessels and collecting vessels and are absent in the initial lymphatics. The valves 
serve to prevent retrograde flow during relaxation of the vessel wall and to promote net 
forward flow [29]. Ideally, the pressure of lymph increases to a certain point due to 
lymph volume or from smooth muscle contraction, the fluid will be pushed through the 
valve into the next chamber of the vessel, lymphangion. As the pressure drops, the open 
valve then closes so that the lymph fluid cannot flow backwards. 
Lymphatic valves are composed of 2 intraluminal leaflets, each of which is 
formed by two layers of LECs separated by an extracellular matrix–rich core [30]. 
Generally, the lymphatic valves are of the bicuspid type, regardless of the species [31]. 
However, up to five leaflet valves as well as single leaflet ones have been observed. 
Studies have shown that smooth muscle cells (SMC) are absent from the valve leaflets 
[8]. The lymphangions, thus, do not have the ability to contract in the valvular regions 
due to absence of SMCs. 
Studies have shown defects in valve formation due to certain genes such as 
FOXC-2 and lymph flow during development. Valvular malformations can promote 
lymphatic system dysfunctions which are discussed in detail in the next section [32]. 
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1.2 Lymphatic System Malfunction 
Abnormal function of lymphatic vessels is important in multiple diseases 
including inflammation and cancer. The lymphatic vessels contribute to a wide range of 
human diseases such as inflammation, lymphatic insufficiency, obesity, hypertension and 
metastasis platform for tumors [3]. Impaired lymphatic function, reduced numbers of 
lymphatic vessels and valvular insufficiencies cause disruption of lymph transport [33].  
The outcome of a disrupted lymphatic system is compromised lymph drainage. The 
lymph is retained in the vessels and the interstitial sites, the ability to maintain fluid 
balance and tissue homeostasis is compromised and immune function can be impaired. 
This condition is one of the most common forms of lymphatic dysfunction and is coined 
lymphedema. 
The two major classifications of lymphedema are primary and secondary [34]. 
Primary lymphedema can be genetic or congenital and can be first noticed birth or it can 
develop later in life during puberty or later. Unlike primary lymphedema, secondary 
lymphedema is caused due to damage to collecting lymphatic vessels. 
Although primary lymphedema is a rare condition, identification of the 
underlying genetic causes has provided insight into the molecular mechanisms regulating 
the development and function of the lymphatic vasculature. Insights into the molecular 
and genetic mechanisms of lymphedema have been greatly enhanced over the last few 
years [20]. This is mainly attributable to:  
(1) the discovery of gene mutations in two different types of lymphedema,  
(2) the identification of specific receptors on LECs 
(3) the recent development of genetic mouse models for cutaneous lymphedema. 
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Two lymphangiogenic factors,  VEGF-C and VEGF-D, and their lymphatic 
receptor VEGFR3 gene have been identified as a major cause of Milroy disease, which 
causes lymphedema due to hypoplasia of lymphatic capillaries and is typically observed 
at birth [3]. Primary lymphedema has been classified as Milroy disease when present at 
birth (Milroy 1892), or as Meige disease, which develops predominantly after puberty 
(Meige 1898). Both diseases are characterized by a combination of dilated lymphatic 
capillaries and interstitial accumulation of lymph fluid leading to lymphedema. Mutations 
in the transcription factor FOXC2 have been linked to lymphedema-distichiasis (LD) 
characterized by late-onset lymphedema and varicose veins [35]. Previous studies of 
FOXC2 mutant mice reveals that LD is due to loss of valves in the collecting vessels. 
Similar results are observed in samples obtained from LD patients [21]. Heterozygous 
missense mutations in α9 integrin (ITGA9) underlie congenital chylothorax in human 
fetuses, recapitulating the results obtained by gene targeting in mice [36]. 
Dominant-negative mutations of the homeobox transcription factor SOX18 have 
been linked with hypotrichosis-lymphedema-telangiectasia syndrome [37]. Mutations in 
the NF-κB regulatory protein NEMO associate with a rare and complex syndrome 
involving lymphedema [38] . 
C-type lectin–like receptor 2 (CLEC2) deficiency in mice develop normal 
lymphatic system, but the lymph flow is opposed by the backflow of blood from the 
venous system as the result of a hemostatic defect [39]. C-type lectin–like receptor 2 
(CLEC2) is a cell-surface receptor and is expressed by platelets. Previous studies have 
reported the presence of lymph flow playing a central and broad role in the development 
of collecting lymphatic vessels and valves [23]. CLEC2-deficient animals with reduced 
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lymph flow, thus, lack lymphatic valves, fail to remodel the primitive mesenteric 
lymphatic plexus into a hierarchical collecting vessel network, and exhibit premature and 
excess smooth muscle cell coverage of their collecting lymphatic vessels. CLEC2-
deficient mice can thus be used as lymphedema models [23].  
Secondary lymphedema is acquired due to damage to the lymphatic vessels due to 
surgery or from lymphatic filariasis [40], caused by a parasitic worm invading the 
lymphatic system. Filariasis causes a complete and permanent disruption of lymphatic 
transport, resulting in chronic lymphedema of the legs and genitals [41]. The onset of 
filariasis is triggered by a filarial-specific inflammatory reaction that promotes the 
production of VEGF, VEGF-C, and VEGF-D, which leads to persistent hyperplasia of 
the lymphatic vessels [42]. Filariasis is the principal cause of lymphedema worldwide, 
affecting approximately 100 million people [42]. Arm lymphedema is very common in 
breast cancer patients as an outcome of node dissection during surgery [8].  
Lymphedema is progressive and lifelong and very few treatments have been 
proposed to restore flow and resolve the lymphedema. The treatment of lymphedema is 
currently based on physiotherapy, compression garments, liposuction, and occasionally 
surgery for manual lymphatic drainage, however, the longevity of the treatment is 
unknown [43].   
1.3 Vascular Fluid Dynamics 
The Reynolds number, Re, is the ratio of the inertial fluid forces to viscous fluid 
forces. At lower values of Reynolds number, the viscous forces dominate the fluid flow. 
It has been noted that the Reynolds number in the collecting lymphatics is small due to 
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the viscosity of the flow and the size of the vessels [44]. It has been assumed that lymph 
is a Newtonian fluid and does not contain solid particles [45], [46]. In Newtonian fluids, 
the viscous stresses are proportional to the local strain rate, 
𝛾 ̇ =  𝑑𝑢/𝑑𝑟 
where μ is the kinematic viscosity of the fluid, u is the tangential velocity component and 
r is the radial spatial variable.  Newton’s law for shear stress is given by: 
𝑊𝑆𝑆 =  𝜇 ∗ ?̇? 
𝑊𝑆𝑆 =  𝜇 ∗
𝑑𝑢
𝑑𝑟
 
 
Normal stresses due to fluid pressure are transferred to all vessel wall layers 
(intima, media and adventitia). In contrast, shear stress is experienced by the cellular 
inner layer, endothelium, in contact with the flowing fluid. 
1.4 Objectives  
Despite the importance of the lymphatic system in health and disease, it remains 
overlooked in terms of research, especially compared with the blood circulatory system 
[48], [49]. The study of the lymphatic system is still in its infancy. Studies of the uptake 
and transport of drugs into the body via the intestinal lymphatic system have received 
increasing attention in recent years. The effective transport of fluid in the lymphatic 
system is important for preventing consequences such as lymphedema. It is essential that 
we understand how various lymphatic diseases alter the vessel mechanical environment. 
Improving our understanding of lymph fluid flow will enhance our knowledge on how 
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lymphatic transport of waste, immune cells, and proteins around the body and potentially 
develop new ways of treating lymphedema by understanding the origins of the disease. 
The primary objective of this study is to compare the effects of single leaflet valve 
malformation in wild type mouse to normal valves within the same animal as well as in 
other wild type mouse. The single leaflet valve is hypothesized to affect the flow and 
thus, effective lymph transport. This mouse serves as a model to study valvular 
insufficiency and malformations that can potentially contribute to lymphedema. 
Biological processes involving endothelial cells are often studied in vitro due to 
the challenging nature of in vivo studies. However, characterizing the flow field 
experienced by LECs in vivo is key to understanding how the lymphatic system functions 
in normal and disease states.  
One example where lymph fluid dynamics may be important is in cancer 
metastasis. The lymphatic system is the metastatic route for various types of cancers. 
Metastasis through lymphatic system is recognized to precede hematological spread in 
many cancers including melanoma, breast, colon, lung and prostate cancers. The 
lymphatics, thus, have the potential to play a large role in anticancer treatment [47]. 
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CHAPTER 2 
EXPERIMENTAL SETUP 
2.1 Experimental Summary 
Four mice were anaesthetized using 2,2,2-Tribromoethanol (Sigma-Aldrich) 
dissolved in tert-amyl alcohol (Sigma-Aldrich) (0.5 mg/g), and body temperature was 
maintained at 37°C throughout experiment [23]. Ventral skin was peeled back to expose 
an inguinal lymph node. The inguinal lymph nodes are located medial to the femoral vein 
and under the cribriform fascia as shown in Figure 2. 
 
Figure 2: Anaesthetized mouse with ventral skin peeled back exposing the inguinal 
lymphatic nodes  
 
 Because the lymphatic network is filled from the periphery, it is difficult to 
globally label lymph, thus, fluorescent particles were introduced in the lymphatics. The 
inguinal lymph node was injected with 5 μl of FluoSpheres (1 μm beads, 580/605, 
Invitrogen) diluted in sterile PBS for a concentration of 1 × 108 beads/ml. The beads were 
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coated with Polyethylene Glycol (PEG), a hydrophilic molecule, to avoid binding of 
particles to each other and to the vessel.  
The efferent (post-nodal) lymphatic vessel was imaged for several minutes 
immediately following bead injection under a dissecting microscope as shown in Figure 
3. Lymphatic endothelial PROX1 green fluorescent protein (GFP) marker enabled 
lymphatic vessel edge detection. 
 
 
Figure 3: Anaesthetized mouse under a dissecting microscope. The efferent vessel to 
inguinal lymphatic node was imaged. 
 
 
 
 16 
 
2.2 Image Acquisition 
Fluorescent-based imaging techniques are commonly implemented in animal 
research to overcome the poor contrast that is often inherent in biological imaging. Live 
animal imaging was conducted as shown in Figure 3 using green and red fluorescence 
and an Olympus MVX10 dissecting microscope. The mice employed expressed PROX1 
green fluorescent protein in LECs. In contrast, the injected particle tracers fluoresced red. 
Particle displacement through efferent lymphatic vessels was imaged for several minutes.  
One of the primary challenges in imaging was the animal moving the plane of interest in 
and out of focus due to breathing and other muscular movements. 
2.3 Mice Specifications 
Two four-week-old wild type mice were considered for the studying the effects of 
single leaflet valve. Additional mouse cases involving a wild type mouse and a Clec2-/- 
Mouse were imaged for further studies. The phenotype of each mouse is described in 
Table 1. The weights of the mice varied from 14 to 25 grams. 
 
 
 
 
 
 
 
 17 
 
Table 1: Mice specifications. Mouse 1 (control) and Mouse 2 were considered for the 
study 
 
Case Phenotype Valves Abbr. 
MOUSE 1 Wild-Type  One normal bi-leaflet valve WT 
MOUSE 2 Wild-Type  Two bi-leaflet valves, 
One uni-leaflet malformed valve 
  
 MV 
MOUSE 3 Wild-Type One normal bi-leaflet valve WT2 
MOUSE 4 Clec2-
Deficient 
Abnormal non-functional valve Clec2-/- 
 
 
Figure 4: Image acquired from WT Mouse and MV Mouse. The green fluorescence 
depicts the labeling of the lymphatic endothelium by PROX-1 GFP. The particles 
stained in red dye are seen in red. 
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Figure 5: Image acquired from WT2 Mouse and Clec2-/- Mouse. The green 
fluorescence depicts the labeling of the lymphatic endothelium by PROX-1 GFP. 
The particles stained in red dye are seen in red. 
 
 
 
Table 2: Mice image specifications 
 
Case Image Size 
(pixels) 
Image Size 
(μm) 
Frame Rate 
(fps) 
Flow Direction 
MOUSE 1 1301 × 305 361 × 85 30 Right to Left 
MOUSE 2 1391 × 181 386 × 50 30 Right to Left 
MOUSE 3 1181 × 246 328 × 68 30 Left to Right 
MOUSE 4 1911 × 841 530 × 233 30 Left to Right 
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2.4 Immunohistochemistry Experiments 
 Based on few previous studies and as discussed in the previous chapter, eNOS 
was found be upregulated in the LECs subjected to higher flow. It was hypothesized that 
the region downstream of valves would be subjected to higher flow velocities and higher 
WSS. To verify this hypothesis, immunohistochemistry (IHC) experiments were 
performed on mouse tissues to study the expression of eNOS in the lymphatics.   
IHC was performed on mesenteric gut acquired from 3 to 10 days old wild-type 
(WT) mice. Greater adipose tissue in the mesentery of older animals increases the degree 
of complexity when imaging the lymphatics, thus mice younger than 10 days were 
selected.  Mesenteric gut was dissected carefully from mice, thus, preserving the 
morphology and the lymphatics surrounding the mesentery. All samples were washed 
three times with PBS (Life Technologies) and fixed with 5% formalin (Fisher). The 
tissues were then washed with PBS along with 0.1% Triton-X (Sigma-Aldrich) (PBS-Tx) 
to promote permeabilization. To minimize nonspecific binding of the primary and 
secondary antibodies, blocking solution casein (Life Technologies) was used for 30-min 
at room temperature followed by adding primary antibodies eNOS (Santa-Cruz 
Biotechnology) and PROX1 (Abcam) diluted 1:120 in blocking solution. The tissues 
were then incubated overnight at 4-degree Celsius. This was followed by three washes in 
PBS-Tx and overnight incubation with the secondary antibodies that were fluorescently 
tagged - Alexa Fluor 488 chicken anti-goat (Life Technologies), diluted 1:250; Alexa 
Fluor 488 donkey anti rabbit (Life Technologies), diluted 1:250. The samples were then 
washed with PBS-Tx in a dark room to avoid photobleaching. The gut was then carefully 
emptied using forceps to remove partially digested food which is auto-fluorescent under a 
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dissecting microscope in a dark room. Smaller samples of tissues were mounted on glass 
slides using vectashield mounting media (Sigma-Aldrich) and cover slips, and examined 
with a confocal microscope. Imaging was performed at 20x and PROX1-GFP enabled the 
detection of lymphatics. 
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CHAPTER 3 
ANALYSIS METHODS 
3.1 Image Processing 
Particle displacement through efferent lymphatic vessels was imaged with a 
dissecting microscope as discussed in Chapter 2. Twenty-five seconds of data were 
selected from each recording with 30 frames per second imaging a single plane for a total 
of 750 fluorescent images. 
A custom denoising program was written for detecting and removing artifacts and 
stabilizing images affected by breathing of the animal, muscle activity, amongst other 
causes. The first image in the series served as the reference image to stabilize all other 
images in the series. First, all images were cross-correlated with the first image to obtain 
a coarse displacement for each image with relation to the first image in the series. The 
coarse displacement data was then used to align the images with respect to the first image 
in the series. A finer image displacement calculation was conducted using the stabilized 
series and the Template Matching and Slice Alignment ImageJ Plugin.  A third run was 
conducted in MATLAB incorporating the two separate displacement datasets. With these 
displacement datasets, the power spectral density was calculated revealing the power 
present in the signal.  Peaks in the signal coincide with animal breathing rate, muscle 
twitching and other physiologically related movements (Figure 6 and Figure 7). 
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Figure 6: Power Spectrum Density for the WT Mouse (Blue) and MV Mouse (Red) 
 
 
 
Figure 7: Power Spectrum Density for WT2 Mouse (Blue) and Clec2–/– Mouse (Red) 
 
ImageJ (National Institutes of Health, Bethesda, MD) and MATLAB 
(MathWorks, Natick, MA) were used for post processing to retrieve data from images 
post hoc such as vessel diameter, particle velocity, etc. as discussed in subsequent 
sections. 
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3.2 Vessel Edge Detection  
We define the process of partitioning an image into multiple segments of pixels as 
image segmentation. All the pixels in a region are similar with respect to some 
characteristic or computed property, such as color, intensity, or texture. These objects can 
be processed or analyzed for the extraction of quantitative information. Live animal data 
can be noisy and consequently difficult to segment accurately. 
Edge detection includes a variety of mathematical methods that aim at identifying 
points in an image at which the image brightness changes sharply or has discontinuities. 
The points at which image brightness changes sharply are typically organized into a set of 
curved line segments termed edges. The discontinuities in an image are found by 
calculating the first and/or second order derivatives of an image. A multi-step algorithm – 
Canny-Deriche edge detector [48] was implemented to identify the set of bright pixels 
from the green channel representing the vessel edge. The green channel in the images 
corresponded to the expression of endothelial Prox1-GFP. 
The pixels representing vessel edge were detected by Canny-Deriche algorithm 
and were stored in file for each frame for each of the mouse cases. Each pixel had an x 
and y coordinate value. The number of pixels stored was dependent on the brightness of 
the edge and clarity of the image. Lesser number of pixels were stored for out of focus 
frames.  
MATLAB was used to analyze the pixel data. A local regression technique was 
implemented to identify the vessel edge curve. The local curve fitting technique helps 
identify accurately the shape of the vessel. However, the fitting varied in successive 
frames. To account for sudden changes in the vessel geometry in successive frames, 
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spatial and temporal smoothing was performed on the fitted curves. Each frame now had 
two sets of x and y coordinates which represented the top and bottom curves of the 
lymphatic vessel (Figure 8). 
The vessel diameter was calculated as the distance between top and bottom curves 
of the vessel after considering the angle of orientation of the lymphangion. The diameter, 
D, was computed at every point of the vessel for all the frames. 
 
Figure 8: Curves showing the outcome of edge detection procedure on a green 
channel image for MV Mouse case 
3.3 Particle Tracking  
Particle tracking velocimetry is a technique to measure velocity of particles that 
are resident in a fluid. This technique is based on Lagrangian approach which involves 
tracking individual particles. The local particle tracking is based on comparison of 
successive frames. To calculate the individual particle shift, sub-regions much smaller 
than the images are analysed from two different successive images acquired Δt time apart 
within that specific interrogation window area.  
Several computational tools are available to assist with detection of shapes or 
particles and to evaluate the trajectories of the identified shapes in a sequence of images. 
Particle tracking tools assume the target particles to be brighter than the local 
background. Image quality and frame rate significantly affect the results of automated 
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particle tracking. Higher frame rate values ensure the distance travelled by a particle is 
lower between the frames.  
3.3.1 Challenges 
A major challenge of particle tracking is the fact that segmented objects at 
different time points may have no relationship between consecutive frames. The steps for 
successful tracking are: 
(i) To correctly identify the objects that should be part of the same track. 
(ii)  To accurately join them as part of a track. 
(iii) To precisely track the objects position even if on occasion the object may 
disappear or reappear.  
The detection of particles in vivo in a two-dimensional focal plane makes particle 
tracking complex because the breathing of the animals renders the plane of interest out of 
focus and blurry. Computationally, blurry particles are labelled as particles with larger 
diameters. Thus, particle tracking tools fail to identify a particle in subsequent frames if it 
changes in size and brightness and the software assigns different labels to the same 
particle in different frames. Particle density and clustering of particles present further 
challenges in unique particle identification. Also, some particles closer to the vessel wall 
tend to be stationary, while particles away from the wall flow over the stationary 
particles. 
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3.3.2 Tracking Tools Used 
ImarisTrack (Bitplane, Belfast, UK) software for two-dimensional images was 
used for initial particle detection and tracking (Figure 9). Due to computer RAM 
limitations, entire sequence of images could not be imported into the software and the 
image sets were into shorter image sequences. Statistical data such as particle 
coordinates, track identification number, span of the tracks was extracted from 
ImarisTrack. A custom MATLAB code was written to combine entire tracking data by 
merging tracks for each mouse case.   
However, due to challenges in tracking as discussed previously, the tracking of 
particles was not accurate.  Particle coordinates from ImarisTrack were converted to .mdf 
files that could be read by the MTrackJ plugin for ImageJ. The MTrackJ plugin offered 
greater manual control for manual tracking and was used for interactive manual trajectory 
inspection, modification and creation.  
 
Figure 9: Sample image depicting the location of detected particles in a frame in the 
WT Mouse 
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3.3.3 Particle Velocity 
A unique identification number was allotted to each particle after manual tracking 
was performed in mTrackJ. The velocity of the particle was computed using the particle 
coordinates from two consecutive frames and calculate as follows. 
ut = Δx/Δt 
 
vt = Δy/Δt 
 
Based on directionality of the flow of the particles, the sign convention was 
defined for each case (Table 3). Forward flow depicts the flow of lymph moving towards 
veins from the interstitium. 
Table 3: Velocity sign convention 
 
Forward moving particle positive + u 
Backward moving particle negative - u 
Upward moving particle positive + v 
Downward moving particle negative - v 
 
3.4 Region of Interests 
Presence of valves and lack of pumping organ promote variable flow fields in the 
lymphatics. Retrograde flow adds to the degree of complexity within the flow. The flow 
fields vary temporally within a single lymphangion as well. In order to compare 
lymphatic fluid flow within different regions of the lymphatic vessels, segments of equal 
width were defined at different regions of the vessels as shown in Figure 10 and Figure 
11. Figure 10 is for the control mouse with a single bi-leaflet valve (WT) and Figure 11 
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for a mouse with one uni-leaflet and two bi-leaflet (MV). Since SMCs are present around 
each lymphangion, it is expected that the vessel contraction is maximum at the center of 
the lymphangions. Hence, the center was defined based on the maximum contraction of 
the vessel within that lymphangion. The distance of the segment downstream from the 
valves was kept at a constant ratio based on the length of the lymphangion. Fluid and 
vessel properties were analyzed in the defined segments. 
 
 
Figure 10: Defined segments in WT Mouse 
 
 
 
 
Figure 11: Defined segments in MV Mouse  
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3.5 Particle Data Interpolation 
The number of particles flowing inside the vessel varied for each mouse case. 
Hence, a custom function was generated to interpolate the particle displacement in order 
to generate a uniformly distributed vector field. Zero velocity no-slip condition was 
considered at the vessel wall and valve surfaces. MATLAB function griddata for two-
dimensional non-uniformly spaced was used to interpolate the values of velocity 
components on a gridded mesh. Triangulation-based cubic interpolation method was 
implemented [49] for second order continuity. 
 
 
Figure 12: Location of actual particles in MV Mouse at a random time point 
 
 
Figure 13: Interpolated pseudo-particles in same frame in MV Mouse 
 
 
Figure 12 shows the coordinates (x, y) of actual particles at an instant within the 
Mouse 2 vessel and Figure 13 shows the uniformly space coordinates inside the vessel. 
The values of velocity, vorticity, shear strain and normal strain were then calculated at all 
points in the interpolated data. 
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 Overview 
 The data presented in this chapter are results after image analysis for two mice. 
WT Mouse and MV Mouse were used to study the effects of valve malformation. The 
comparison of valves or regions was based on calculations in segments defined in section 
3.4. Vessel contraction, fluid velocity, development of velocity profiles within a flow 
cycle, variable trajectory of particles, flow fields changes within a flow cycle, wall shear 
stress, vorticity and strain were calculated and compared. A lymphatic universal flow 
function is proposed.   
4.2 Vessel Contraction Over Time 
Differences in vessel diameter were observed in each animal. The value of 
diameter changed from lymphangion to lymphangion within the same animal as well. 
Due to heterogeneity in vessel size and, normalization techniques were implemented for 
comparison of parameters in different animals.  
Figure 14 shows the movement of vessel or the change in vessel diameter at 
defined segments in WT Mouse and MV Mouse. Vessel diameter is expressed in terms of 
non-dimensional diameter (D/Dmax), wherein D/Dmax = 1, represents the maximum vessel 
diameter in that particular segment. Maximum vessel diameter implies vessel in dilated 
form and smaller values indicate contracted vessel due to the SMCs and other factors. 
Elastin helps contracted vessel to retain its shape. 
 31 
 
In diameter analysis of WT and MV Mice cases, the maximum contraction was 
observed at the center of the lymphangion and no contraction was observed in the 
valvular regions. This confirms that the absence of SMCs yield no vessel contraction.in 
the valve region of collecting lymphatics. However, the contraction at the center segment 
of the lymphangions is greatest (Figure 14a) for WT Mouse, wherein gray and black 
curves depict center of two neighboring lymphangions. The segment immediately 
downstream of the uni-leaflet valve was found to contract less in comparison to the 
segment downstream of bi-leaflet valve in MV Mouse (Figure 14b). 
The contraction pattern observed in three cases was different and no correlation 
was found in the correlation study. The maximum vessel contraction observed was 
approximately 9% and 16 % in WT and MV, respectively. The contraction differences in 
comparison to different cases and even within the same animal in different lymphangions 
shows the heterogeneity of the lymphatic system. 
 
 32 
 
 
 
Figure 14: (a) Changes in vessel diameter (D) in WT Mouse at three segments for 25 
seconds. Red (solid) curve depicts the segment downstream of the normal bi-leaflet 
valve, gray (dashed) and black (double-dashed) curves represent the segments at 
center of the lymphangions; (b) Changes in vessel diameter (D) in MV Mouse at 
three segments for 25 seconds. Red (solid) curve depicts the segment downstream of 
the bi-leaflet valve, green (dashed) curve depicts the segment downstream of the 
uni-leaflet valve and black (double-dashed) curve represents the segment at center 
of the lymphangion 
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4.3 Fluid Velocity  
 Particle velocity of each tracked particle was computed in MATLAB as discussed 
in previous chapter. Radial velocity profile was plotted based on the streamwise velocity 
u values of each particle within the segment. The particles within the segment were 
assumed to be positioned at the center plane of the segment, the plane at which diameter 
was calculated. Based on the particle velocities, velocity values were plotted and marked 
as solid dots in Figure 15. Higher order spline curve fits were used for curve 
representations of the velocity profile as shown in Figure 15. 
 
 
Figure 15: Sample velocity profile. The solid points on the curve represent the actual 
streamwise velocity value (u) of the particles in the segment. The red curve 
represents a spline curve fit.  
 
 
 The aggregate velocity U in the plane was computed by integration of fitted 
velocity curve profile. This technique was implemented to calculate U for all the defined 
segments at each of 750-time points spanning 25 seconds. 
 Linear flow rate of the fluid Q* was defined as the product of velocity u to the 
diameter D of the segment.  
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Q* = u*D 
The changes in the values of Q* were compared for multiple segments and is 
shown in Figure 16. The values of Q* are proportional to the values of U by the factor of 
vessel diameter. However due to challenges in particle tracking and presence of lesser 
number of particles at an instantaneous time points, U values could not be estimated. Q* 
values represented in Figure 16 show the curve fit of Q* values from the actual data. As 
seen in the figure, the velocity of the fluid is observed to have negative values as well. 
The negative values of U or Q* implies retrograde flow within that segment. The flow in 
MV was observed to reverse even in the presence of valves – both normal and 
malformed. The flow was observed to be reversing in the valvular segment as well which 
showcases the presence of inter-lymphangion retrograde flow even in presence of valves. 
The differences in magnitudes of the flow rate varied for different cases and it is just an 
account of heterogeneity of the lymphatic system.  
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Figure 16: Changes in flow rate (Q*) at three segments for 25 seconds in (a) WT 
Mouse -  Red (solid) curve depicts the segment downstream of the normal bi-leaflet 
valve, gray (dashed) and black (double-dashed) curves represent the segment at 
center of the lymphangions; (b) MV Mouse - Red (solid) curve depicts the segment 
downstream of the bi-leaflet valve, green (dashed) curve depicts the segment 
downstream of the uni-leaflet valve and black (double-dashed) curve represents the 
segment at center of the lymphangion 
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4.4 Flow Cycles 
 Individual flow cycles were selected starting with first point that flow reverses 
until it reverses again. The temporal span of flow cycles Tcycle varies for each mouse and 
varies differently for each segment in a mouse vessel. This highlights the heterogeneity in 
lymphatic flow. The absence of a pumping organ is the primary contributing factor for 
this irregularity.   
 Different flow cycles were identified and Tcycle was found to be different in all the 
cycles. For comparison of cycles in different segments and different mouse cases, a new 
term (τ) was defined. τ rescales all the flow cycles from 0 to 1. Zero value of τ defines the 
start of flow cycle (retrograde flow) and one defines the end of flow cycle. 
 
τ = 
𝐓 − 𝐦𝐢𝐧 (𝐓𝐜𝐲𝐜𝐥𝐞)
𝐦𝐚𝐱 (𝐓𝐜𝐲𝐜𝐥𝐞) − 𝐦𝐢𝐧(𝐓𝐜𝐲𝐜𝐥𝐞)
 
 
 One cycle was selected for both WT and MV Mice. The values of velocity u over 
the span of this cycle can be seen in Figure 17. The differences in time of each time cycle 
was overcome by changing the time scale from time in seconds to τ as defined 
previously. Segment 3 from WT Mouse was not considered in this analysis due to lesser 
number of particles in the segment and particles being out of focus. For both cases, the 
antegrade flow direction dominated implying a net forward flow in both cases. 
 To study the localized effects in each segment over the cycle, we calculated the 
velocity profiles (as discussed earlier) at five values of τ: 0.0, 0.25, 0.5, 0.75, 1.0 for each 
cycle. The diameter was normalized to compare the nature of the velocity profile. The 
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diameter of vessel changes over the cycle span for both mice as seen in previous section. 
The diameter was normalized as follows: 
D* = 
𝑫 − 𝒎𝒊𝒏 (𝑫)
𝒎𝒂𝒙 (𝑫) − 𝒎𝒊𝒏(𝑫)
 
where D* ranges from 0 to 1. A value of 1 represents the largest diameter for that segment 
and corresponding to maximal vessel dilation. A value of zero for D* implies the vessel 
walls are touching. The velocity profiles for five time points were plotted with respect to 
D* for two cases and is shown in Figure 18. 
 
 
Figure 17: One flow cycle at segments. (a) WT Mouse - Red (solid) curve depicts the 
segment downstream of the normal bi-leaflet valve, black (double-dashed) curve 
represents the segment at center of the lymphangion, segment at the center of 
upstream lymphangion was ignored in this study due to absence of sufficient 
particles in the focal plane in that segment. (b) MV Mouse - Red (solid) curve 
depicts the segment downstream of the bi-leaflet valve, green (dashed) curve depicts 
the segment downstream of the uni-leaflet valve and black (double-dashed) curve 
represents the segment at center of the lymphangion 
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Figure 18: Velocity profiles at the segments at five time points (τ = 0.0, 0.25, 0.5, 
0.75, 1.0) within one cycle. The solid points show the actual u value of the particles. 
The solid curve represents spline fit. (a) WT Mouse - Red curve depicts the segment 
downstream of the normal bi-leaflet valve, black curve represents the segment at 
center of the lymphangion; (b) MV Mouse - Red curve depicts the segment 
downstream of the bi-leaflet valve, green curve depicts the segment downstream of 
the uni-leaflet valve and black curve represents the segment at center of the 
lymphangion 
 
 
At τ = 0, as seen in Figure 17, the flow is transitioning from forward flow to 
backward flow. The velocity values are closer to zero in all segments. The velocity 
profile is more parabolic at τ = 0.5. The profile becomes further parabolic at the valvular 
segment (Red curve) in WT Mouse at τ = 0.75. The region downstream of the normal 
valve (Red curve) in MV Mouse shows a more parabolic profile in comparison to region 
downstream of malformed valve (Green curve). 
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4.5 Flow Cycle Universality 
 Figure 19 shows two flow cycles each for the three segments in WT Mouse. Thus, 
the total number of flow cycles plotted are six. Curve peaks were found to properly shift 
the curves such that (t/tcycle) = 0 corresponds to the maximum peak of each curve. The 
maximum u value of multiple peaks (Umax) differed in amplitude. Interestingly, the 
lowest cycle-Umax was 50% of the highest value of Umax. Thus, adding another key finding 
to the observation of heterogeneity of lymphatic flow cycles. Figure 19a shows u/Umax 
plotted on t/tcycle scale and peaks shifted to zero for WT.  
Similarly, three flow cycles each for three segments in MV were plotted using the 
same methods described before (Figure 19b). Thus, 9 flow cycles were considered for 
MV Mouse for this study. 
The u values for all the cycles for each mouse were averaged such that one curve 
was generated representing the average of all the flow cycles. Analysis was performed on 
these two averaged curves based on methodology shown in Figure 20. The time scale t 
was rescaled to t/t0, where t0 is difference in time from peak (of u value: Umax) to time 
when the amplitude u0 is 50% of the amplitude u0 as shown in Figure 20. Velocity u was 
normalized on scale of from 0 to 1 as follows: 
u*  = 
𝐮 − 𝐦𝐢𝐧 (𝐮)
𝐦𝐚𝐱 (𝐮) − 𝐦𝐢𝐧(𝐮)
 = 
𝐮 − 𝐦𝐢𝐧 (𝐮)
𝒖𝟎
  
 
A value of zero on the normalized velocity scale can also imply retrograde flow. 
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Figure 19: Multiple flow cycles (u/Umax) within one animal at different segments 
plotted on a normalized time scale (t/tcycle), curve peaks shifted such that (t/tcycle) = 0. 
(a) Six flow cycles from three segments in WT Mouse; (b) Nine flow cycles from 
three segments in MV Mouse 
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Figure 20: Universality function analysis methodology. The dotted line represents a 
sample average flow cycle depicting multiple flow cycles within the same animal.   
 
 
 
The two averaged cycles were then plotted using a t/t0 time scale. A Gaussian 
curve fitting method was used to find the best curve representing the average of these two 
curves by optimizing the errors as shown in the black curve in Figure 21. The function 
f(η) = e-0.95 η2 represents a potential universal lymphatic flow curve. 
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Figure 21: Lymphatic universal flow cycle function. The blue curve represents the 
average flow cycle for WT Mouse. The red curve represents the average flow cycle 
for MV Mouse. The solid black curve shows a Gaussian curve fit for the two curves. 
 
4.6 Particle Trajectory 
A particle located in a valve recirculation zone, a particle travelling in the vessel 
lumen and particle in contact with the valve surface were considered for a trajectory 
study comparison in WT and MV. The length of time corresponding to the tracking of 
these particles was one flow cycle, the same flow cycle previously selected. Wall shear 
stress values were calculated whenever the particle was in contact with the wall. Figure 
22 shows the trajectory of the particles and the estimated WSS. The hollow circles in the 
trajectory plots represents the particle moving in the antegrade direction and the solid 
dots represent retrograde travel. 
The particle moving in the vessel lumen and traveling over the normal valve 
surface in WT Mouse during intra-lymphangion transport traveled the most and covered 
roughly 100 microns. On the other hand, displacement of similar particle in MV Mouse 
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traveling over the uni-leaflet valve was roughly 15 microns. Interestingly, a particle 
moving and in contact with the endothelium on the vessel wall (Blue) travelled a longer 
distance than the particle in the lumen (Black) in the case of MV (Figure 22d). The WSS 
was higher on both valve and vessel wall endothelium in WT Mouse in comparison to 
MV Mouse potentially affecting differential gene expression in the endothelium.  
The valve, both uni-leaflet and bi-leaflet, promote a fluid recirculation zone 
beneath the leaflets. It was observed that particles in this region do not displace and 
recirculate in form of eddies in that region. The trajectory of two such particles – one 
underneath each valve was studied. It could be seen in all trajectory plots that the particle 
followed the same path during flow reversal as during forward flow (Figure 22). This is 
characteristic of low Reynolds number flow and lymph flow has very low Reynolds 
number as detailed in Chapter 1. 
The presence of a single leaflet valve affected the overall inter-lymphangion 
transport of the fluid in comparison to a normal bi-leaflet valve. Localized slower 
transport of lymph can affect the fluid accumulation in the upstream. If this type of 
valvular is more widespread, it could potentially lead to retarded lymph transport - 
lymphedema. 
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Figure 22: Comparison of trajectories of three particles within the vessel for span of 
one flow cycle. The selected particles were in recirculation zone (Red), along the 
vessel wall (Blue) and traveling over the valve surface (Black). Wall shear stress 
(WSS) experienced by three particles of different trajectories in WT Mouse (a) and 
MV Mouse (b); Trajectory of three particles in WT Mouse (c) and MV Mouse (d). 
Hollow circles represent antegrade direction whereas solid circles represent 
retrograde direction of travel; (e) Trajectory of a particle within the recirculating 
zone of normal bi-leaflet valve in WT Mouse; (f)Trajectory of a particle within the 
recirculating zone of malformed uni-leaflet valve in MV Mouse 
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4.7 Comparison of Flow Fields in a Flow Cycle 
 Interpolated data of the velocities was compared at five points in the cycles with 
no slip condition at the vessel and valve edges. The time points were same as used in 
previous studies; τ = 0.0, 0.25, 0.5, 0.75 and 1.0. Figures 23 and 24 show the velocity 
vector fields in the lymphatic vessels for WT Mouse and MV Mouse respectively. 
 It can be observed that the flow reversal is faster in the valves than in the 
lymphangions. Higher velocities are observed at the center of the vessel lumen. WT 
Mouse has higher fluid velocity in comparison to MV Mouse, showing heterogeneity of 
lymphatics in different animals. 
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Figure 23: Vector plots depicting the flow field at various times in the flow cycle (τ = 
0.0, 0.25, 0.5, 0.75, 1.0) for WT Mouse.   
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Figure 24: Vector plots depicting the flow field at various times in the flow cycle (τ = 
0.0, 0.25, 0.5, 0.75, 1.0) for MV Mouse 
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In Figure 24, for MV Mouse, at τ = 0.5 and 0.75, when the fluid is transported 
forward towards the venous system, higher fluid flow is observed from the lymphangion 
upstream of a normal valve than from the lymphangion upstream of the unileaflet valve. 
This suggests the possiblity of fluid obstruction due to single leaflet valve. Also, it can be 
observed that at τ = 0.5 and 0.75, higher velocities are experienced closer to the vessel 
wall due to the malformed valve. Thus, affecting the stresses experienced by LECs in that 
region. 
WSS was computed at the segments defined previously in both WT Mouse and 
MV Mouse. Figure 25 shows the values of WSS in these segments at both top surface 
and bottom surfaces of the vessels. The WSS magnitude values was within 1.2 dyne/cm2. 
It can be noted that the higher values of WSS was observed when the flow rate was 
higher (τ = 0.5, 0.75).  
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Figure 25: Vessel Wall Shear Stress (WSS) from interpolated velocity data at five 
time points (τ = 0.0, 0.25, 0.5, 0.75, 1.0) in the flow cycle. (a, b) WSS calculated at top 
and bottom edge of the vessel respectively in three segments for WT Mouse. Red bar 
depicts the segment downstream of the normal bi-leaflet valve, gray and black bars 
represent the segments at center of the lymphangions; (c, d) WSS calculated at top 
and bottom edge of the vessel respectively in three segments for MV Mouse - Red 
bar depicts the segment downstream of the bi-leaflet valve, green bar depicts the 
segment downstream of the uni-leaflet valve and black bar represents the segment 
at center of the lymphangion 
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4.8 Vorticity and Strain Fields 
 Vorticity describes the spinning motion experienced by the lymph. Figure 26 and 
27 shows the vorticity field in the vessels for WT Mouse and MV Mouse at five time-
points in the flow cycle. The positive and negative signs describe the direction of 
spinning. Higher vorticity regions were observed near the valves in both WT and MV 
Mice. Higher flow rate (τ = 0.5, 0.75) promote higher vorticity regions in the vessels. 
Higher vorticity regions can potentially be regions for flow separation and are mostly 
seen downstream of the valves. 
 The fluid deformation represented by normal and shear strain is represented in 
Figures 28, 29, 30 and 31 for both cases. Narrowing of vessel within the valve regions 
promote higher normal and shear strain fields as seen in the figures.  
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Figure 26:  Vorticity field within the vessel at various times in a flow cycle (τ = 0.0. 
0.25. 0.5, 0.75, 1.0) for WT Mouse 
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Figure 27: Vorticity field within the vessel at various times in a flow cycle (τ = 0.0. 
0.25. 0.5, 0.75, 1.0) for MV Mouse 
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Figure 28: Normal strain field within the vessel at various times in a flow cycle (τ = 
0.0. 0.25. 0.5, 0.75, 1.0) for WT Mouse 
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Figure 29: Normal strain field within the vessel at various times in a flow cycle (τ = 
0.0. 0.25. 0.5, 0.75, 1.0) for MV Mouse 
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Figure 30: Shear strain field within the vessel at various times in a flow cycle (τ = 
0.0. 0.25. 0.5, 0.75, 1.0) for WT Mouse 
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Figure 31: Shear strain field within the vessel at various times in a flow cycle (τ = 
0.0. 0.25. 0.5, 0.75, 1.0) for MV Mouse 
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CHAPTER 5 
CONCLUSION 
 
This study explores the effects of a single leaflet valve in wild-type mouse 
lymphatic vessels by studying the lymph transport in vivo. Presence of retrograde was 
observed flow in wild-type mice models even in presence of valves. The lymphatic 
system is a complex network of smaller initial and pre-collecting lymphatics and larger 
collecting lymphatics. Thus, it should be noted that flow of particles was studied in just 
one of these vessels among a complex network of lymphatic vessels.   
Initial immunohistochemistry experiments failed to show signals for both PROX-
1 and eNOS. Increasing the permeabilization time helped with PROX-1 signal. This way, 
the lymphatic network could be identified. However, localized expression of eNOS on 
LECs was not clearly observed. This experiment can be performed to study the presence 
of different protein expressions within the same vessel. 
Future works include studying the flow and effects of flow in genetically 
modified models. Lymphocytes can be labeled instead of injecting particles, to further 
enhance our understanding of lymph transport in vivo. Also, increasing the sampling size 
can help understand the effects of malformation in better way. The universality flow 
function computed in this study can also be verified for by increasing the sampling size, 
both looking at different mouse models and different regions within the same animal.   
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